May 11, 2017May 12, 2017May 13, 2017

May 11, 2017

 

TIME MEETING HALL A
08:30 – 10:00 ACUTE MYELOID LEUKEMIA
Scientific Chairs: Jacob Rowe (Shaare Zedek Medical Center, Jerusalem, Israel), Siret Ratip (Acıbadem Kozyatagi Hospital, Istanbul, Turkey)

  • Novel Agents in AML: Eytan Stein (Memorial Sloan Kettering Cancer Center, New York, USA)
  • Transplants for AML in First Complete Remission: Nicolaus Kröger (University Medical Center Hamburg-Eppendorf, Hamburg, Germany)
  • Importance of MRD in AML: Jacob Rowe (Shaare Zedek Medical Center, Jerusalem, Israel)
10:00 – 10:30 COFFEE BREAK
10:30 – 12:00 MULTIPLE MYELOMA
Scientific Chairs: Evangelos Terpos (University of Athens School of Medicine,Alexandra General Hospital, Athens, Greece), Güner Hayri Özsan (Dokuz Eylül University, Izmir, Turkey)

  • Optimal Therapy for Newly Diagnosed Patients Who Are Eligible for Autologous Transplantation:Evangelos Terpos (University of Athens School of Medicine, Alexandra General Hospital, Athens, Greece)
  • Can MRD Tailor Therapy for Myeloma Patients? : C. Ola Landgren (Memorial Sloan Kettering Cancer Center, New York, USA)
  • Emerging Problems with the Use of Monoclonal Antibodies in the Everyday Management of Myeloma Patients: Efstathios Kastritis (National and Kapodistrian University of Athens School of Medicine, Athens, Greece)
12:00 – 13:15 LUNCH POSTER DISCUSSION
13:15 – 14:15

SATELLITE SYMPOSIUM

Scientific Chair: Ali Zahit Bolaman (Adnan Menderes University, Aydın, Turkey)

New Era in the Treatment of Relapsed / Refractory Multiple Myeloma: Evangelos Terpos (University of Athens School of Medicine, Alexandra General Hospital, Athens, Greece)
14:15 – 14:30 BREAK
14:30 – 16:00 DIFFUSE LARGE B-CELL LYMPHOMA
Scientific Chairs: Christian Gisselbrecht (Hospital Saint Louis, Paris, France), Levent Ündar (Akdeniz University, Antalya, Turkey)

  • Update on Pathology  with  New WHO Classification: Thierry Jo Molina (Necker University Hospital, Paris, France)
  • Relapse DLBCL Where Are We With ASCT?: Christian Gisselbrecht (Hospital Saint Louis, Paris, France)
16:00 – 16:30 COFFEE BREAK
16:30 – 17:30 BCR/ABL NEGATIVE CHRONIC MYELOPROLIFERATIVE DISORDERS
Scientific Chairs: Francesca Palandri (University of Bologna, Italy), Fahir Özkalemkaş (Uludag University, Bursa, Turkey)

  • Philadelphia – Negative Chronic Myeloproliferative Neoplasms: Diagnostic Criteria and Personalized Therapy in 2017: Francesca Palandri (University of Bologna, Italy)
18:00 – 19:30 OPENING CEREMONY